Regulatory Filings

TSXHLS

Description	Date	Format
News release - English	Dec 21, 2020
News release - English	Dec 16, 2020
News release - English	Dec 14, 2020
News release - English	Nov 19, 2020
News release - English	Nov 17, 2020
News release - English	Nov 16, 2020
News release - English	Nov 12, 2020
News release - English	Nov 5, 2020
News release - English	Oct 27, 2020
News release - English	Oct 22, 2020
News release - English	Sep 30, 2020
News release - English	Sep 3, 2020
News release - English	Aug 31, 2020
News release - English	Aug 7, 2020
News release - English	Aug 6, 2020
News release - English	Jul 30, 2020
News release - English	Jul 20, 2020
News release - English	Jun 19, 2020
News release - English	Jun 17, 2020
News release - English	Jun 10, 2020
News release - English	Jun 1, 2020
News release - English	Jun 1, 2020
News release - English	May 21, 2020
News release - English	May 7, 2020
News release - English	Apr 30, 2020
1-25 26-31

SEDAR® is a registered trade-mark of and property of the Alberta Securities Commission

HLS Therapeutics Inc.

HLS provides access to
treatments critical to patients
and their caregivers with the
brand names they trust.

Site Menu

Contact Info

1-647-495-9000

10 Carlson Court, Suite 701
Etobicoke, Ontario, M9W 6L2

U.S. Privacy Policy | Canada Privacy Policy | Terms of Use

WS0004_0